Aim Attention‐deficit/hyperactivity disorder (ADHD) is associated with dysregulation of dopamine and norepinephrine neurotransmission. Extended‐release methylphenidate (MPH), a first‐line treatment for ADHD, modulates these systems. However, its specific effects on the dopamine transporter (DAT) and norepinephrine transporter (NET) are inadequately ...
Masaki Oya +21 more
wiley +1 more source
Correction: Tetrahydrocannabinol and dopamine D1 receptor. [PDF]
Lee J.
europepmc +1 more source
Interaction Between Oxytocin and Dopamine Signaling: Focus on the Striatum. [PDF]
Guidolin D +5 more
europepmc +1 more source
New-Onset Gambling Addiction Following Treatment for Psychosis With Cariprazine. [PDF]
Hashmi M, Nguyen A, Ilyas H.
europepmc +1 more source
Resolving the heterogeneity of dopamine subsystems dysfunction in schizophrenia: a PET meta-analysis. [PDF]
Zhao Z +13 more
europepmc +1 more source
Pharmacological Insights into Optimal Dosing in Burning Mouth Syndrome: A Narrative Review of the Non-Linear Actions of Amitriptyline and Aripiprazole. [PDF]
Nagamine T.
europepmc +1 more source
Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia. [PDF]
Lewandrowski KU +23 more
europepmc +1 more source
Computational modelling identifies key determinants of subregion-specific dopamine dynamics in the striatum. [PDF]
Ejdrup A +7 more
europepmc +1 more source
Effect of dopamine on TGF-β2 secretion by human retinal pigment epithelial cells and the underlying mechanism. [PDF]
Fan J +6 more
europepmc +1 more source
The role of nucleus accumbens dopamine signaling in the development of morphine tolerance in neuropathic pain. [PDF]
Cui S +6 more
europepmc +1 more source

